Hemay005 tablets

DRUG2 trials

Sponsors

Ganzhou Hemay Pharmaceutical Co., Ltd

Conditions

COPD (Chronic Obstructive Pulmonary Disease)Moderate to Severe Ulcerative Colitis

Phase 2

Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis

Active, not recruitingNCT05486104

Ganzhou Hemay Pharmaceutical Co., LtdModerate to Severe Ulcerative Colitis

Start: 2022-11-08End: 2026-12-30Updated: 2026-04-03

A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD

Not yet recruitingNCT07314242

Ganzhou Hemay Pharmaceutical Co., LtdCOPD (Chronic Obstructive Pulmonary Disease)

Start: 2026-01-01End: 2027-12-31Target: 120Updated: 2026-01-02